Cargando…
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
Immunotherapy with chimeric antigen receptor T (CAR-T cells) has been recently approved for patients with relapsed/refractory B-lymphoproliferative neoplasms. Along with great efficacy in patients with poor prognosis, CAR-T cells have been also linked with novel toxicities in a significant portion o...
Autores principales: | Gavriilaki, Eleni, Sakellari, Ioanna, Gavriilaki, Maria, Anagnostopoulos, Achilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312228/ https://www.ncbi.nlm.nih.gov/pubmed/32485958 http://dx.doi.org/10.3390/ijms21113886 |
Ejemplares similares
-
Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents
por: Gavriilaki, Maria, et al.
Publicado: (2019) -
Thrombocytopenia in COVID-19: pathophysiology matters
por: Gavriilaki, Eleni, et al.
Publicado: (2020) -
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
por: Demosthenous, Christos, et al.
Publicado: (2021) -
Neurologic complications after allogeneic transplantation: a meta‐analysis
por: Gavriilaki, Maria, et al.
Publicado: (2019) -
An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)